AIDS News and Research

RSS

Mayo Clinic licenses non-exclusive rights to Expression Pathology's Liquid Tissue patent

Expression Pathology, a leader in tissue proteomic analysis, today announced Mayo Clinic has licensed non-exclusive rights to Expression Pathology's Liquid Tissue® patent for use in diagnosis of systemic amyloidosis in formalin-fixed tissue.

18 Nov 2009

Health, policy experts gather for 3-day conference on family planning

By offering family planning services to people seeking HIV/AIDS information and treatment, Africa's population growth rate could be curbed by 2.5 percent, health experts said Monday during an international family health conference in Kampala, Uganda, Agence France-Presse reports (11/16).

18 Nov 2009

Global Alliance for Chronic Diseases announces targets

The Global Alliance for Chronic Diseases (GACD) on Monday outlined plans "to invest tens of millions of dollars in heart and lung disease studies in a battle against a global epidemic of chronic disease," over five years, Reuters reports.

17 Nov 2009

Also in global health news: Global corruption; HIV vaccine; smoking; DRC aid

A new report from Transparency International says the fight against corruption worldwide is slowing as urgency to address the global economic downturn recedes, Bloomberg reports.

17 Nov 2009

AIDS advocates ask White House to send money south

WLBT: "The White House Office of National AIDS Policy chose Jackson [Mississipppi] to host an HIV/AIDS town hall meeting Monday night. The community discussion allowed Mississippians to give feedback that will be included in a national strategy to end the HIV/AIDS epidemic. ... Many asked for sex and STD education in the schools, more doctors and transportation funding in rural areas and health insurance" (Anderson, 11/17).

17 Nov 2009

AAPHP: E-cigarettes are not wildly dangerous alternatives as they have been portrayed

In July of this year, the Food and Drug Administration released a study that condemned electronic cigarettes as an unsafe alternative for smokers, but not all physicians are convinced that the study was accurate or even completely transparent to the tax payers that fund them.

17 Nov 2009

Scientists solve 50-year-old thalidomide puzzle

Research into the controversial drug thalidomide reveals that the mechanism through which the drug causes limb defects is the same process which causes it to damage internal organs and other tissues. The article, published in Bio-Essays, outlines the challenges surrounding thalidomide research and claims that confirmation of a 'common mechanism' could lead to new treatments for Leprosy, Crohn's Disease, AIDS and some forms of cancer..

17 Nov 2009

Business professors available for expert commentary on how PPPs can help fight HIV/AIDS

The following professors from the University of Virginia's Darden School of Business are available for expert commentary on how public-private partnerships (PPPs) can help win the fight against HIV/AIDS in cities throughout the United States.

17 Nov 2009

Global Alliance for Chronic Disease to fight against chronic non-communicable diseases

An alliance of institutions collectively managing an estimated 80 percent of all public health research funding worldwide today announced their first targets for concerted action in the fight against "chronic non-communicable diseases" (CNCDs).

17 Nov 2009

Power of prevention in women's hands: NYC scales up access to the second-generation female condom

African Services Committee is praising New York City's Department of Health, for showing national leadership in putting the second-generation female condom into the hands of women living with or at risk of HIV/AIDS infection.

17 Nov 2009

CD4 Initiative selects Zyomyx's CD4 POC technology as best for measuring CD4 T-cell count in HIV/AIDS patients

Zyomyx, Inc., a leader in chip-based bioanalysis technologies, today announced that its readerless CD4 point-of-care (POC) technology was selected by Imperial College London's CD4 Initiative as the best-performing POC test method for measuring CD4 T-cell count in HIV/AIDS patients. Zyomyx's CD4 assay is now the only remaining POC product being supported by the CD4 Initiative.

17 Nov 2009

Economic crisis impacts health department capacity to address rising STD rates

Amid the mounting toll of budget cuts across the country, a new study from the National Coalition of STD Directors (NCSD) shows just how much an impact the economic crisis is having on sexually transmitted disease (STD) programs and in turn, having more broadly on public health infrastructure.

17 Nov 2009

Targeted Genetics announces third quarter 2009 results; reports net income of $0.03 per common share

Targeted Genetics Corporation today announced its financial results for the third quarter ended September 30, 2009.

17 Nov 2009

Opinions: Health system funding; malnutrition assistance; social dimension of HIV

"For too long, global health funding has gone to diseases like AIDS with the most vocal lobby groups and not to the diseases with the greatest need," Philip Stevens, a senior fellow at International Policy Network, writes in a Business Daily opinion piece.

16 Nov 2009

Also in Global Health News: HIV/AIDS in Uganda; medical equipment in Tanzania; birth control in Afghanistan; Ethiopia malaria fight

"The Uganda AIDS Commission (UAC) is revamping its national HIV information campaign after HIV prevention messages were less successful than hoped," PlusNews reports. "Campaigns aimed at ending cross-generational sex will be abandoned in favour of generic warnings about engaging in risky sex because of fears that young people may believe that sex within their own generation is risk-free. Officials have also said factors such as alcohol abuse, which predispose people to risky sexual behaviour, must be tackled alongside HIV prevention" (11/16).

16 Nov 2009

ECR Pharmaceuticals to commercialize and manufacture ZolpiMist in the U.S. and Canada

NovaDel Pharma Inc. today announced its entry into an exclusive license and distribution agreement with ECR Pharmaceuticals Company, Inc., a wholly owned subsidiary of Hi-Tech Pharmacal Co., Inc. to commercialize and manufacture ZolpiMist™ in the United States and Canada. ZolpiMist™ is our oral spray formulation of zolpidem tartrate approved by the FDA in December of 2008.

16 Nov 2009

Researchers, decision makers, and people with HIV to attend Ontario HIV Treatment Network's conference

The 11th annual research conference of the Ontario HIV Treatment Network will examine the factors that increase risk for individuals and communities most affected by HIV, as well as interventions that may improve the lives of people living with HIV and prevent the spread of the virus.

16 Nov 2009

HIRC recognizes CDPHP for offering best disease management program in upstate New York

Health Dialog Services Corporation, a leading provider of healthcare decision programs, today announced that its client, Capital District Physicians’ Health Plan, Inc. (CDPHP®), has been recognized by the Health Industries Research Cos. (HIRC) for offering the best disease management program in upstate New York.

16 Nov 2009

NIH offers $1.6 million, three-year grant to Prism Clinical Imaging

Prism Clinical Imaging, Inc., in collaboration with investigators at The Medical College of Wisconsin in Milwaukee, has received a $1.6 million, three-year grant from the National Institutes of Health (NIH) to develop and clinically validate advanced medical imaging software that aids the diagnosis and treatment of patients with brain cancer.

16 Nov 2009

SPOT: A one-stop HIV and sexually transmitted diseases testing center for youth

In the last 10 years, the St. Louis area has seen an alarming increase in new diagnoses of HIV and sexually transmitted infections among 13-24 year-olds. Between 1997-2007, more than 50 new diagnoses of HIV were made each year among adolescents and young adults, who are often disconnected from the health-care system or support services. Nationwide, St. Louis has among the highest rates of sexually transmitted diseases in this age group.

16 Nov 2009

AIDS News and Research

Mayo Clinic licenses non-exclusive rights to Expression Pathology's Liquid Tissue patent

Health, policy experts gather for 3-day conference on family planning

Global Alliance for Chronic Diseases announces targets

Also in global health news: Global corruption; HIV vaccine; smoking; DRC aid

AIDS advocates ask White House to send money south

AAPHP: E-cigarettes are not wildly dangerous alternatives as they have been portrayed

Scientists solve 50-year-old thalidomide puzzle

Business professors available for expert commentary on how PPPs can help fight HIV/AIDS

Global Alliance for Chronic Disease to fight against chronic non-communicable diseases

Power of prevention in women's hands: NYC scales up access to the second-generation female condom

CD4 Initiative selects Zyomyx's CD4 POC technology as best for measuring CD4 T-cell count in HIV/AIDS patients

Economic crisis impacts health department capacity to address rising STD rates

Targeted Genetics announces third quarter 2009 results; reports net income of $0.03 per common share

Opinions: Health system funding; malnutrition assistance; social dimension of HIV

Also in Global Health News: HIV/AIDS in Uganda; medical equipment in Tanzania; birth control in Afghanistan; Ethiopia malaria fight

ECR Pharmaceuticals to commercialize and manufacture ZolpiMist in the U.S. and Canada

Researchers, decision makers, and people with HIV to attend Ontario HIV Treatment Network's conference

HIRC recognizes CDPHP for offering best disease management program in upstate New York

NIH offers $1.6 million, three-year grant to Prism Clinical Imaging

SPOT: A one-stop HIV and sexually transmitted diseases testing center for youth

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News